nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—breast cancer	0.313	0.821	CbGaD
Gemfibrozil—CYP3A4—breast cancer	0.0681	0.179	CbGaD
Gemfibrozil—CYP1A2—Anastrozole—breast cancer	0.0249	0.0654	CbGbCtD
Gemfibrozil—CYP1A2—Toremifene—breast cancer	0.0228	0.0598	CbGbCtD
Gemfibrozil—CYP2C9—Anastrozole—breast cancer	0.0224	0.0589	CbGbCtD
Gemfibrozil—CYP2C8—Lapatinib—breast cancer	0.0215	0.0564	CbGbCtD
Gemfibrozil—SLCO1B1—Irinotecan—breast cancer	0.0195	0.0512	CbGbCtD
Gemfibrozil—CYP2C19—Lapatinib—breast cancer	0.018	0.0473	CbGbCtD
Gemfibrozil—CYP3A4—Exemestane—breast cancer	0.0172	0.0452	CbGbCtD
Gemfibrozil—CYP2C9—Idarubicin—breast cancer	0.017	0.0447	CbGbCtD
Gemfibrozil—CYP2C8—Raloxifene—breast cancer	0.0163	0.0427	CbGbCtD
Gemfibrozil—CYP3A4—Letrozole—breast cancer	0.0146	0.0384	CbGbCtD
Gemfibrozil—CYP3A4—Anastrozole—breast cancer	0.013	0.0343	CbGbCtD
Gemfibrozil—CYP3A4—Toremifene—breast cancer	0.0119	0.0313	CbGbCtD
Gemfibrozil—CYP3A4—Fulvestrant—breast cancer	0.0111	0.0291	CbGbCtD
Gemfibrozil—CYP2C8—Tamoxifen—breast cancer	0.0107	0.0282	CbGbCtD
Gemfibrozil—SLCO1B1—Methotrexate—breast cancer	0.0103	0.0271	CbGbCtD
Gemfibrozil—CYP3A4—Thiotepa—breast cancer	0.00988	0.026	CbGbCtD
Gemfibrozil—CYP2C9—Capecitabine—breast cancer	0.00931	0.0245	CbGbCtD
Gemfibrozil—CYP3A4—Ixabepilone—breast cancer	0.00904	0.0237	CbGbCtD
Gemfibrozil—CYP2C19—Tamoxifen—breast cancer	0.00901	0.0237	CbGbCtD
Gemfibrozil—CYP3A4—Lapatinib—breast cancer	0.0087	0.0229	CbGbCtD
Gemfibrozil—CYP2C8—Paclitaxel—breast cancer	0.00836	0.022	CbGbCtD
Gemfibrozil—CYP1A2—Tamoxifen—breast cancer	0.00832	0.0218	CbGbCtD
Gemfibrozil—CYP2C8—Fluorouracil—breast cancer	0.00792	0.0208	CbGbCtD
Gemfibrozil—CYP2C9—Tamoxifen—breast cancer	0.00749	0.0197	CbGbCtD
Gemfibrozil—CYP3A4—Raloxifene—breast cancer	0.00659	0.0173	CbGbCtD
Gemfibrozil—CYP1A2—Fluorouracil—breast cancer	0.00613	0.0161	CbGbCtD
Gemfibrozil—CYP2C9—Paclitaxel—breast cancer	0.00583	0.0153	CbGbCtD
Gemfibrozil—CYP2C9—Fluorouracil—breast cancer	0.00552	0.0145	CbGbCtD
Gemfibrozil—CYP3A4—Vinorelbine—breast cancer	0.00483	0.0127	CbGbCtD
Gemfibrozil—CYP3A4—Tamoxifen—breast cancer	0.00436	0.0114	CbGbCtD
Gemfibrozil—CYP3A4—Mitoxantrone—breast cancer	0.00425	0.0112	CbGbCtD
Gemfibrozil—CYP3A4—Paclitaxel—breast cancer	0.00339	0.00891	CbGbCtD
Gemfibrozil—CYP3A4—Irinotecan—breast cancer	0.00335	0.00879	CbGbCtD
Gemfibrozil—CYP3A4—Vinblastine—breast cancer	0.00297	0.00781	CbGbCtD
Gemfibrozil—CYP3A4—Docetaxel—breast cancer	0.00245	0.00644	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—breast cancer	0.00183	0.0048	CbGbCtD
Gemfibrozil—PPARA—embryo—breast cancer	0.000947	0.0921	CbGeAlD
Gemfibrozil—SLCO1B1—mammary gland—breast cancer	0.000885	0.086	CbGeAlD
Gemfibrozil—PPARA—epithelium—breast cancer	0.000773	0.0751	CbGeAlD
Gemfibrozil—PPARA—skin of body—breast cancer	0.000735	0.0714	CbGeAlD
Gemfibrozil—PPARA—adipose tissue—breast cancer	0.000625	0.0607	CbGeAlD
Gemfibrozil—PPARA—female reproductive system—breast cancer	0.000574	0.0558	CbGeAlD
Gemfibrozil—PPARA—adrenal gland—breast cancer	0.00056	0.0545	CbGeAlD
Gemfibrozil—PPARA—female gonad—breast cancer	0.000523	0.0508	CbGeAlD
Gemfibrozil—CYP2C8—mammary gland—breast cancer	0.000503	0.0489	CbGeAlD
Gemfibrozil—PPARA—endocrine gland—breast cancer	0.000486	0.0472	CbGeAlD
Gemfibrozil—CYP2C9—mammary gland—breast cancer	0.000447	0.0434	CbGeAlD
Gemfibrozil—CYP1A2—nipple—breast cancer	0.00039	0.0378	CbGeAlD
Gemfibrozil—SLCO1B1—female reproductive system—breast cancer	0.000366	0.0356	CbGeAlD
Gemfibrozil—PPARA—lymph node—breast cancer	0.000336	0.0326	CbGeAlD
Gemfibrozil—SLCO1B1—endocrine gland—breast cancer	0.00031	0.0301	CbGeAlD
Gemfibrozil—CYP2C8—endometrium—breast cancer	0.000251	0.0244	CbGeAlD
Gemfibrozil—CYP2C8—pituitary gland—breast cancer	0.000227	0.0221	CbGeAlD
Gemfibrozil—CYP2C8—female reproductive system—breast cancer	0.000208	0.0202	CbGeAlD
Gemfibrozil—CYP2C19—endocrine gland—breast cancer	0.000202	0.0196	CbGeAlD
Gemfibrozil—CYP2C9—female reproductive system—breast cancer	0.000185	0.018	CbGeAlD
Gemfibrozil—CYP2C8—endocrine gland—breast cancer	0.000176	0.0171	CbGeAlD
Gemfibrozil—CYP1A2—endocrine gland—breast cancer	0.000165	0.016	CbGeAlD
Gemfibrozil—CYP2C9—endocrine gland—breast cancer	0.000157	0.0152	CbGeAlD
Gemfibrozil—CYP3A4—female reproductive system—breast cancer	0.000141	0.0137	CbGeAlD
Gemfibrozil—CYP3A4—endocrine gland—breast cancer	0.000119	0.0116	CbGeAlD
Gemfibrozil—Chest pain—Capecitabine—breast cancer	4.69e-05	0.000341	CcSEcCtD
Gemfibrozil—Myalgia—Capecitabine—breast cancer	4.69e-05	0.000341	CcSEcCtD
Gemfibrozil—Constipation—Paclitaxel—breast cancer	4.68e-05	0.00034	CcSEcCtD
Gemfibrozil—Pain—Paclitaxel—breast cancer	4.68e-05	0.00034	CcSEcCtD
Gemfibrozil—Confusional state—Docetaxel—breast cancer	4.68e-05	0.00034	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	4.65e-05	0.000338	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—breast cancer	4.65e-05	0.000338	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—breast cancer	4.64e-05	0.000337	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Docetaxel—breast cancer	4.64e-05	0.000337	CcSEcCtD
Gemfibrozil—Oedema—Docetaxel—breast cancer	4.64e-05	0.000337	CcSEcCtD
Gemfibrozil—Pruritus—Gemcitabine—breast cancer	4.63e-05	0.000336	CcSEcCtD
Gemfibrozil—Nausea—Thiotepa—breast cancer	4.62e-05	0.000335	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—breast cancer	4.61e-05	0.000335	CcSEcCtD
Gemfibrozil—Diarrhoea—Mitoxantrone—breast cancer	4.59e-05	0.000334	CcSEcCtD
Gemfibrozil—Diarrhoea—Irinotecan—breast cancer	4.59e-05	0.000334	CcSEcCtD
Gemfibrozil—Shock—Docetaxel—breast cancer	4.56e-05	0.000332	CcSEcCtD
Gemfibrozil—Nervous system disorder—Docetaxel—breast cancer	4.55e-05	0.000331	CcSEcCtD
Gemfibrozil—Pruritus—Fluorouracil—breast cancer	4.55e-05	0.00033	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Docetaxel—breast cancer	4.54e-05	0.00033	CcSEcCtD
Gemfibrozil—Confusional state—Capecitabine—breast cancer	4.53e-05	0.000329	CcSEcCtD
Gemfibrozil—Feeling abnormal—Paclitaxel—breast cancer	4.51e-05	0.000328	CcSEcCtD
Gemfibrozil—Skin disorder—Docetaxel—breast cancer	4.51e-05	0.000327	CcSEcCtD
Gemfibrozil—Oedema—Capecitabine—breast cancer	4.49e-05	0.000326	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Paclitaxel—breast cancer	4.48e-05	0.000325	CcSEcCtD
Gemfibrozil—Diarrhoea—Gemcitabine—breast cancer	4.47e-05	0.000325	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—breast cancer	4.46e-05	0.000324	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—breast cancer	4.45e-05	0.000323	CcSEcCtD
Gemfibrozil—Dizziness—Irinotecan—breast cancer	4.44e-05	0.000323	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—breast cancer	4.42e-05	0.000322	CcSEcCtD
Gemfibrozil—Shock—Capecitabine—breast cancer	4.42e-05	0.000321	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—breast cancer	4.42e-05	0.000321	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—breast cancer	4.41e-05	0.000321	CcSEcCtD
Gemfibrozil—Nervous system disorder—Capecitabine—breast cancer	4.4e-05	0.00032	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—breast cancer	4.4e-05	0.00032	CcSEcCtD
Gemfibrozil—Diarrhoea—Fluorouracil—breast cancer	4.4e-05	0.00032	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Capecitabine—breast cancer	4.4e-05	0.00032	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—breast cancer	4.38e-05	0.000318	CcSEcCtD
Gemfibrozil—Skin disorder—Capecitabine—breast cancer	4.36e-05	0.000317	CcSEcCtD
Gemfibrozil—Urticaria—Paclitaxel—breast cancer	4.35e-05	0.000316	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—breast cancer	4.33e-05	0.000315	CcSEcCtD
Gemfibrozil—Abdominal pain—Paclitaxel—breast cancer	4.33e-05	0.000314	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—breast cancer	4.29e-05	0.000312	CcSEcCtD
Gemfibrozil—Vomiting—Mitoxantrone—breast cancer	4.27e-05	0.00031	CcSEcCtD
Gemfibrozil—Vomiting—Irinotecan—breast cancer	4.27e-05	0.00031	CcSEcCtD
Gemfibrozil—Dizziness—Fluorouracil—breast cancer	4.25e-05	0.000309	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—breast cancer	4.24e-05	0.000308	CcSEcCtD
Gemfibrozil—Rash—Mitoxantrone—breast cancer	4.23e-05	0.000308	CcSEcCtD
Gemfibrozil—Rash—Irinotecan—breast cancer	4.23e-05	0.000308	CcSEcCtD
Gemfibrozil—Dermatitis—Mitoxantrone—breast cancer	4.23e-05	0.000307	CcSEcCtD
Gemfibrozil—Dermatitis—Irinotecan—breast cancer	4.23e-05	0.000307	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Docetaxel—breast cancer	4.23e-05	0.000307	CcSEcCtD
Gemfibrozil—Headache—Irinotecan—breast cancer	4.2e-05	0.000306	CcSEcCtD
Gemfibrozil—Headache—Mitoxantrone—breast cancer	4.2e-05	0.000306	CcSEcCtD
Gemfibrozil—Paraesthesia—Docetaxel—breast cancer	4.17e-05	0.000303	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—breast cancer	4.16e-05	0.000302	CcSEcCtD
Gemfibrozil—Vomiting—Gemcitabine—breast cancer	4.16e-05	0.000302	CcSEcCtD
Gemfibrozil—Somnolence—Docetaxel—breast cancer	4.12e-05	0.0003	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—breast cancer	4.12e-05	0.0003	CcSEcCtD
Gemfibrozil—Rash—Gemcitabine—breast cancer	4.12e-05	0.0003	CcSEcCtD
Gemfibrozil—Dermatitis—Gemcitabine—breast cancer	4.12e-05	0.000299	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—breast cancer	4.12e-05	0.000299	CcSEcCtD
Gemfibrozil—Headache—Gemcitabine—breast cancer	4.1e-05	0.000298	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Capecitabine—breast cancer	4.09e-05	0.000297	CcSEcCtD
Gemfibrozil—Vomiting—Fluorouracil—breast cancer	4.09e-05	0.000297	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—breast cancer	4.09e-05	0.000297	CcSEcCtD
Gemfibrozil—Dyspepsia—Docetaxel—breast cancer	4.08e-05	0.000297	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—breast cancer	4.05e-05	0.000295	CcSEcCtD
Gemfibrozil—Rash—Fluorouracil—breast cancer	4.05e-05	0.000295	CcSEcCtD
Gemfibrozil—Dermatitis—Fluorouracil—breast cancer	4.05e-05	0.000294	CcSEcCtD
Gemfibrozil—Paraesthesia—Capecitabine—breast cancer	4.03e-05	0.000293	CcSEcCtD
Gemfibrozil—Headache—Fluorouracil—breast cancer	4.03e-05	0.000293	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—breast cancer	4.01e-05	0.000292	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Docetaxel—breast cancer	4.01e-05	0.000291	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—breast cancer	4e-05	0.000291	CcSEcCtD
Gemfibrozil—Fatigue—Docetaxel—breast cancer	4e-05	0.000291	CcSEcCtD
Gemfibrozil—Nausea—Mitoxantrone—breast cancer	3.99e-05	0.00029	CcSEcCtD
Gemfibrozil—Nausea—Irinotecan—breast cancer	3.99e-05	0.00029	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—breast cancer	3.97e-05	0.000288	CcSEcCtD
Gemfibrozil—Constipation—Docetaxel—breast cancer	3.97e-05	0.000288	CcSEcCtD
Gemfibrozil—Pain—Docetaxel—breast cancer	3.97e-05	0.000288	CcSEcCtD
Gemfibrozil—Dyspepsia—Capecitabine—breast cancer	3.95e-05	0.000287	CcSEcCtD
Gemfibrozil—Asthenia—Paclitaxel—breast cancer	3.93e-05	0.000285	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—breast cancer	3.89e-05	0.000283	CcSEcCtD
Gemfibrozil—Nausea—Gemcitabine—breast cancer	3.88e-05	0.000282	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Capecitabine—breast cancer	3.88e-05	0.000282	CcSEcCtD
Gemfibrozil—Fatigue—Capecitabine—breast cancer	3.87e-05	0.000281	CcSEcCtD
Gemfibrozil—Pruritus—Paclitaxel—breast cancer	3.87e-05	0.000281	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—breast cancer	3.86e-05	0.000281	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—breast cancer	3.86e-05	0.00028	CcSEcCtD
Gemfibrozil—Pain—Capecitabine—breast cancer	3.84e-05	0.000279	CcSEcCtD
Gemfibrozil—Constipation—Capecitabine—breast cancer	3.84e-05	0.000279	CcSEcCtD
Gemfibrozil—Feeling abnormal—Docetaxel—breast cancer	3.82e-05	0.000278	CcSEcCtD
Gemfibrozil—Nausea—Fluorouracil—breast cancer	3.82e-05	0.000277	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—breast cancer	3.81e-05	0.000277	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Docetaxel—breast cancer	3.79e-05	0.000276	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—breast cancer	3.79e-05	0.000275	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—breast cancer	3.78e-05	0.000275	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—breast cancer	3.76e-05	0.000273	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—breast cancer	3.75e-05	0.000273	CcSEcCtD
Gemfibrozil—Diarrhoea—Paclitaxel—breast cancer	3.74e-05	0.000272	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—breast cancer	3.72e-05	0.000271	CcSEcCtD
Gemfibrozil—Feeling abnormal—Capecitabine—breast cancer	3.7e-05	0.000269	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—breast cancer	3.68e-05	0.000268	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Capecitabine—breast cancer	3.67e-05	0.000267	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—breast cancer	3.67e-05	0.000267	CcSEcCtD
Gemfibrozil—Abdominal pain—Docetaxel—breast cancer	3.67e-05	0.000267	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—breast cancer	3.67e-05	0.000267	CcSEcCtD
Gemfibrozil—Dizziness—Paclitaxel—breast cancer	3.62e-05	0.000263	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—breast cancer	3.61e-05	0.000263	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—breast cancer	3.6e-05	0.000262	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—breast cancer	3.58e-05	0.00026	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—breast cancer	3.57e-05	0.000259	CcSEcCtD
Gemfibrozil—Urticaria—Capecitabine—breast cancer	3.57e-05	0.000259	CcSEcCtD
Gemfibrozil—Abdominal pain—Capecitabine—breast cancer	3.55e-05	0.000258	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—breast cancer	3.55e-05	0.000258	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—breast cancer	3.54e-05	0.000258	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—breast cancer	3.5e-05	0.000254	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—breast cancer	3.49e-05	0.000253	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—breast cancer	3.49e-05	0.000253	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—breast cancer	3.49e-05	0.000253	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—breast cancer	3.48e-05	0.000253	CcSEcCtD
Gemfibrozil—Vomiting—Paclitaxel—breast cancer	3.48e-05	0.000253	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—breast cancer	3.47e-05	0.000252	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.46e-05	0.000252	CcSEcCtD
Gemfibrozil—Rash—Paclitaxel—breast cancer	3.45e-05	0.000251	CcSEcCtD
Gemfibrozil—Dermatitis—Paclitaxel—breast cancer	3.45e-05	0.000251	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—breast cancer	3.45e-05	0.00025	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—breast cancer	3.44e-05	0.00025	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—breast cancer	3.44e-05	0.00025	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—breast cancer	3.43e-05	0.000249	CcSEcCtD
Gemfibrozil—Headache—Paclitaxel—breast cancer	3.43e-05	0.000249	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—breast cancer	3.37e-05	0.000245	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—breast cancer	3.37e-05	0.000245	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—breast cancer	3.35e-05	0.000243	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—breast cancer	3.34e-05	0.000243	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—breast cancer	3.34e-05	0.000243	CcSEcCtD
Gemfibrozil—Asthenia—Docetaxel—breast cancer	3.33e-05	0.000242	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—breast cancer	3.32e-05	0.000241	CcSEcCtD
Gemfibrozil—Pruritus—Docetaxel—breast cancer	3.28e-05	0.000239	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—breast cancer	3.28e-05	0.000238	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—breast cancer	3.28e-05	0.000238	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—breast cancer	3.27e-05	0.000238	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—breast cancer	3.26e-05	0.000237	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—breast cancer	3.26e-05	0.000237	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—breast cancer	3.26e-05	0.000237	CcSEcCtD
Gemfibrozil—Nausea—Paclitaxel—breast cancer	3.25e-05	0.000236	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—breast cancer	3.25e-05	0.000236	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.24e-05	0.000236	CcSEcCtD
Gemfibrozil—Asthenia—Capecitabine—breast cancer	3.22e-05	0.000234	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—breast cancer	3.19e-05	0.000232	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—breast cancer	3.18e-05	0.000231	CcSEcCtD
Gemfibrozil—Pruritus—Capecitabine—breast cancer	3.18e-05	0.000231	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—breast cancer	3.18e-05	0.000231	CcSEcCtD
Gemfibrozil—Diarrhoea—Docetaxel—breast cancer	3.17e-05	0.000231	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—breast cancer	3.16e-05	0.000229	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—breast cancer	3.13e-05	0.000227	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—breast cancer	3.13e-05	0.000227	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—breast cancer	3.12e-05	0.000227	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—breast cancer	3.1e-05	0.000225	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—breast cancer	3.08e-05	0.000224	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—breast cancer	3.07e-05	0.000223	CcSEcCtD
Gemfibrozil—Diarrhoea—Capecitabine—breast cancer	3.07e-05	0.000223	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—breast cancer	3.07e-05	0.000223	CcSEcCtD
Gemfibrozil—Dizziness—Docetaxel—breast cancer	3.07e-05	0.000223	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—breast cancer	3.06e-05	0.000223	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—breast cancer	3.05e-05	0.000221	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—breast cancer	3.04e-05	0.000221	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—breast cancer	3.02e-05	0.000219	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—breast cancer	3.02e-05	0.000219	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—breast cancer	3.02e-05	0.000219	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—breast cancer	3e-05	0.000218	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3e-05	0.000218	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—breast cancer	2.97e-05	0.000216	CcSEcCtD
Gemfibrozil—Dizziness—Capecitabine—breast cancer	2.97e-05	0.000216	CcSEcCtD
Gemfibrozil—Vomiting—Docetaxel—breast cancer	2.95e-05	0.000214	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—breast cancer	2.94e-05	0.000214	CcSEcCtD
Gemfibrozil—Rash—Docetaxel—breast cancer	2.93e-05	0.000213	CcSEcCtD
Gemfibrozil—Dermatitis—Docetaxel—breast cancer	2.92e-05	0.000212	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—breast cancer	2.92e-05	0.000212	CcSEcCtD
Gemfibrozil—Headache—Docetaxel—breast cancer	2.91e-05	0.000211	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—breast cancer	2.9e-05	0.00021	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—breast cancer	2.9e-05	0.00021	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—breast cancer	2.89e-05	0.00021	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—breast cancer	2.88e-05	0.00021	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—breast cancer	2.86e-05	0.000208	CcSEcCtD
Gemfibrozil—Vomiting—Capecitabine—breast cancer	2.86e-05	0.000208	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—breast cancer	2.85e-05	0.000207	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—breast cancer	2.85e-05	0.000207	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—breast cancer	2.84e-05	0.000206	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—breast cancer	2.83e-05	0.000206	CcSEcCtD
Gemfibrozil—Rash—Capecitabine—breast cancer	2.83e-05	0.000206	CcSEcCtD
Gemfibrozil—Dermatitis—Capecitabine—breast cancer	2.83e-05	0.000206	CcSEcCtD
Gemfibrozil—Headache—Capecitabine—breast cancer	2.81e-05	0.000204	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—breast cancer	2.81e-05	0.000204	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—breast cancer	2.81e-05	0.000204	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—breast cancer	2.78e-05	0.000202	CcSEcCtD
Gemfibrozil—Nausea—Docetaxel—breast cancer	2.76e-05	0.0002	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—breast cancer	2.76e-05	0.0002	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—breast cancer	2.75e-05	0.0002	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—breast cancer	2.73e-05	0.000199	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—breast cancer	2.7e-05	0.000196	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—breast cancer	2.7e-05	0.000196	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—breast cancer	2.68e-05	0.000194	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—breast cancer	2.68e-05	0.000194	CcSEcCtD
Gemfibrozil—Nausea—Capecitabine—breast cancer	2.67e-05	0.000194	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—breast cancer	2.66e-05	0.000193	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—breast cancer	2.64e-05	0.000192	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.64e-05	0.000192	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—breast cancer	2.6e-05	0.000189	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—breast cancer	2.58e-05	0.000187	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—breast cancer	2.57e-05	0.000187	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—breast cancer	2.56e-05	0.000186	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—breast cancer	2.55e-05	0.000185	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—breast cancer	2.5e-05	0.000182	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—breast cancer	2.5e-05	0.000181	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—breast cancer	2.49e-05	0.000181	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—breast cancer	2.48e-05	0.00018	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—breast cancer	2.48e-05	0.00018	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—breast cancer	2.47e-05	0.00018	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—breast cancer	2.4e-05	0.000174	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—breast cancer	2.39e-05	0.000173	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—breast cancer	2.37e-05	0.000172	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—breast cancer	2.37e-05	0.000172	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—breast cancer	2.3e-05	0.000167	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—breast cancer	2.29e-05	0.000166	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—breast cancer	2.29e-05	0.000166	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—breast cancer	2.25e-05	0.000163	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—breast cancer	2.21e-05	0.000161	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—breast cancer	2.21e-05	0.000161	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—breast cancer	2.14e-05	0.000156	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—breast cancer	2.13e-05	0.000155	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—breast cancer	2.11e-05	0.000153	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—breast cancer	2.11e-05	0.000153	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—breast cancer	2.09e-05	0.000152	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—breast cancer	2.08e-05	0.000151	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—breast cancer	2.07e-05	0.00015	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—breast cancer	2.05e-05	0.000149	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—breast cancer	1.99e-05	0.000145	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—breast cancer	1.99e-05	0.000144	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—breast cancer	1.98e-05	0.000144	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—breast cancer	1.97e-05	0.000143	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—breast cancer	1.97e-05	0.000143	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—breast cancer	1.96e-05	0.000142	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—breast cancer	1.91e-05	0.000139	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—breast cancer	1.86e-05	0.000135	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—breast cancer	1.84e-05	0.000134	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—breast cancer	1.83e-05	0.000133	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—breast cancer	1.82e-05	0.000133	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—breast cancer	1.81e-05	0.000132	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—breast cancer	1.72e-05	0.000125	CcSEcCtD
Gemfibrozil—CYP3A4—Metabolism—ABCC1—breast cancer	3.8e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—breast cancer	3.8e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ACHE—breast cancer	3.8e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.8e-06	4.2e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.79e-06	4.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP3A4—breast cancer	3.78e-06	4.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.77e-06	4.16e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOA2—breast cancer	3.76e-06	4.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1B1—breast cancer	3.72e-06	4.11e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.68e-06	4.07e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MED12—breast cancer	3.67e-06	4.06e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—DPYD—breast cancer	3.67e-06	4.06e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HSP90AA1—breast cancer	3.65e-06	4.03e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—FASN—breast cancer	3.65e-06	4.03e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BCHE—breast cancer	3.63e-06	4.01e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDOA—breast cancer	3.62e-06	3.99e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP17A1—breast cancer	3.6e-06	3.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC5A5—breast cancer	3.59e-06	3.96e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS1—breast cancer	3.56e-06	3.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ENO1—breast cancer	3.56e-06	3.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NCOA1—breast cancer	3.55e-06	3.92e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.55e-06	3.92e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA3—breast cancer	3.51e-06	3.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.5e-06	3.87e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—STK11—breast cancer	3.5e-06	3.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP19A1—breast cancer	3.5e-06	3.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP2D6—breast cancer	3.49e-06	3.86e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A2—breast cancer	3.49e-06	3.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA4—breast cancer	3.48e-06	3.84e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA9—breast cancer	3.48e-06	3.84e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC2A1—breast cancer	3.46e-06	3.83e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NQO1—breast cancer	3.46e-06	3.83e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.45e-06	3.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOA2—breast cancer	3.43e-06	3.79e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CPT1A—breast cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCG2—breast cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTR—breast cancer	3.41e-06	3.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.39e-06	3.75e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX2—breast cancer	3.39e-06	3.74e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA2—breast cancer	3.39e-06	3.74e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CD—breast cancer	3.38e-06	3.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP3A4—breast cancer	3.38e-06	3.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.36e-06	3.71e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HPGDS—breast cancer	3.35e-06	3.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX4—breast cancer	3.35e-06	3.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SULT1A1—breast cancer	3.35e-06	3.7e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—AKT1—breast cancer	3.34e-06	3.69e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALB—breast cancer	3.34e-06	3.68e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HBA1—breast cancer	3.33e-06	3.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—FASN—breast cancer	3.33e-06	3.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1B1—breast cancer	3.32e-06	3.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BCHE—breast cancer	3.31e-06	3.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.28e-06	3.63e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC5A5—breast cancer	3.27e-06	3.61e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—IDH1—breast cancer	3.27e-06	3.61e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTA1—breast cancer	3.27e-06	3.61e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.26e-06	3.6e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—COMT—breast cancer	3.25e-06	3.59e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—breast cancer	3.25e-06	3.59e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ACHE—breast cancer	3.25e-06	3.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTP1—breast cancer	3.24e-06	3.57e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NAT2—breast cancer	3.23e-06	3.57e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMOX1—breast cancer	3.19e-06	3.53e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—breast cancer	3.19e-06	3.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ITPR1—breast cancer	3.19e-06	3.52e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—breast cancer	3.18e-06	3.51e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOA1—breast cancer	3.17e-06	3.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC2A1—breast cancer	3.16e-06	3.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NQO1—breast cancer	3.16e-06	3.49e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—STK11—breast cancer	3.12e-06	3.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP19A1—breast cancer	3.12e-06	3.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.09e-06	3.42e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP3A4—breast cancer	3.08e-06	3.4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP17A1—breast cancer	3.07e-06	3.39e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.06e-06	3.38e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCB1—breast cancer	3.06e-06	3.38e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS1—breast cancer	3.04e-06	3.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ENO1—breast cancer	3.04e-06	3.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.03e-06	3.35e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1B1—breast cancer	3.03e-06	3.34e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TYMS—breast cancer	3.01e-06	3.32e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.99e-06	3.31e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2D6—breast cancer	2.98e-06	3.3e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.97e-06	3.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NCOR1—breast cancer	2.97e-06	3.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTM1—breast cancer	2.97e-06	3.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.97e-06	3.28e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CB—breast cancer	2.95e-06	3.25e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.93e-06	3.24e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA2—breast cancer	2.93e-06	3.23e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—breast cancer	2.92e-06	3.22e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—COMT—breast cancer	2.9e-06	3.21e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTP1—breast cancer	2.89e-06	3.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOA1—breast cancer	2.89e-06	3.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMOX1—breast cancer	2.85e-06	3.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GPX1—breast cancer	2.85e-06	3.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—STK11—breast cancer	2.85e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP19A1—breast cancer	2.85e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ITPR1—breast cancer	2.84e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—FASN—breast cancer	2.84e-06	3.14e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—DPYD—breast cancer	2.83e-06	3.13e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MED12—breast cancer	2.83e-06	3.13e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BCHE—breast cancer	2.83e-06	3.12e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1A1—breast cancer	2.82e-06	3.11e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ERCC2—breast cancer	2.8e-06	3.09e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC5A5—breast cancer	2.79e-06	3.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDOA—breast cancer	2.79e-06	3.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCB1—breast cancer	2.74e-06	3.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA3—breast cancer	2.71e-06	2.99e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC2A1—breast cancer	2.7e-06	2.98e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NQO1—breast cancer	2.7e-06	2.98e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A2—breast cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TYMS—breast cancer	2.69e-06	2.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.67e-06	2.95e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTM1—breast cancer	2.66e-06	2.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.66e-06	2.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NCOR1—breast cancer	2.66e-06	2.93e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—COMT—breast cancer	2.65e-06	2.92e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.64e-06	2.92e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CPT1A—breast cancer	2.64e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTR—breast cancer	2.64e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCG2—breast cancer	2.64e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTP1—breast cancer	2.63e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP3A4—breast cancer	2.63e-06	2.91e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—MTHFR—breast cancer	2.63e-06	2.9e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.62e-06	2.89e-05	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—AKT1—breast cancer	2.6e-06	2.87e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMOX1—breast cancer	2.6e-06	2.87e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ITPR1—breast cancer	2.59e-06	2.86e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1B1—breast cancer	2.59e-06	2.86e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HPGDS—breast cancer	2.58e-06	2.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HBA1—breast cancer	2.57e-06	2.84e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTEN—breast cancer	2.55e-06	2.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GPX1—breast cancer	2.54e-06	2.81e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.54e-06	2.8e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1A1—breast cancer	2.52e-06	2.78e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ACHE—breast cancer	2.51e-06	2.77e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—breast cancer	2.51e-06	2.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ERCC2—breast cancer	2.5e-06	2.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCB1—breast cancer	2.49e-06	2.75e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOA1—breast cancer	2.47e-06	2.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TYMS—breast cancer	2.45e-06	2.7e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP19A1—breast cancer	2.43e-06	2.69e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—STK11—breast cancer	2.43e-06	2.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CAV1—breast cancer	2.42e-06	2.68e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.42e-06	2.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTM1—breast cancer	2.42e-06	2.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NCOR1—breast cancer	2.42e-06	2.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP17A1—breast cancer	2.37e-06	2.62e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS1—breast cancer	2.35e-06	2.59e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ENO1—breast cancer	2.35e-06	2.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—MTHFR—breast cancer	2.35e-06	2.59e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GPX1—breast cancer	2.32e-06	2.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.32e-06	2.56e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2D6—breast cancer	2.3e-06	2.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1A1—breast cancer	2.3e-06	2.53e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.28e-06	2.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ERCC2—breast cancer	2.28e-06	2.51e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—COMT—breast cancer	2.26e-06	2.5e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA2—breast cancer	2.26e-06	2.5e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTP1—breast cancer	2.25e-06	2.49e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMOX1—breast cancer	2.22e-06	2.45e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ITPR1—breast cancer	2.22e-06	2.45e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CG—breast cancer	2.21e-06	2.44e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—FASN—breast cancer	2.19e-06	2.42e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BCHE—breast cancer	2.18e-06	2.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CAV1—breast cancer	2.16e-06	2.39e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC5A5—breast cancer	2.16e-06	2.38e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—MTHFR—breast cancer	2.14e-06	2.36e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCB1—breast cancer	2.13e-06	2.35e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TYMS—breast cancer	2.09e-06	2.31e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NQO1—breast cancer	2.08e-06	2.3e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC2A1—breast cancer	2.08e-06	2.3e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTM1—breast cancer	2.07e-06	2.28e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NCOR1—breast cancer	2.07e-06	2.28e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.07e-06	2.28e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.07e-06	2.28e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1B1—breast cancer	2e-06	2.21e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GPX1—breast cancer	1.98e-06	2.19e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CAV1—breast cancer	1.97e-06	2.18e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CG—breast cancer	1.97e-06	2.18e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1A1—breast cancer	1.96e-06	2.17e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.96e-06	2.16e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ERCC2—breast cancer	1.95e-06	2.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CD—breast cancer	1.94e-06	2.14e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALB—breast cancer	1.92e-06	2.12e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOA1—breast cancer	1.91e-06	2.1e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.89e-06	2.08e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—STK11—breast cancer	1.88e-06	2.07e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP19A1—breast cancer	1.88e-06	2.07e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—breast cancer	1.83e-06	2.02e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—MTHFR—breast cancer	1.83e-06	2.02e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CG—breast cancer	1.8e-06	1.99e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.8e-06	1.98e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—COMT—breast cancer	1.75e-06	1.93e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTP1—breast cancer	1.74e-06	1.92e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CD—breast cancer	1.73e-06	1.91e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMOX1—breast cancer	1.71e-06	1.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALB—breast cancer	1.71e-06	1.89e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ITPR1—breast cancer	1.71e-06	1.89e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CB—breast cancer	1.69e-06	1.87e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CAV1—breast cancer	1.69e-06	1.86e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—breast cancer	1.68e-06	1.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCB1—breast cancer	1.64e-06	1.82e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—breast cancer	1.64e-06	1.81e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TYMS—breast cancer	1.62e-06	1.78e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.61e-06	1.78e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NCOR1—breast cancer	1.6e-06	1.76e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTM1—breast cancer	1.6e-06	1.76e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.6e-06	1.76e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CD—breast cancer	1.58e-06	1.75e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALB—breast cancer	1.56e-06	1.72e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CG—breast cancer	1.54e-06	1.7e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GPX1—breast cancer	1.53e-06	1.69e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1A1—breast cancer	1.51e-06	1.67e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CB—breast cancer	1.51e-06	1.67e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ERCC2—breast cancer	1.5e-06	1.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—breast cancer	1.5e-06	1.65e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—breast cancer	1.49e-06	1.65e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—AKT1—breast cancer	1.47e-06	1.62e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTEN—breast cancer	1.46e-06	1.61e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—MTHFR—breast cancer	1.41e-06	1.56e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CB—breast cancer	1.38e-06	1.52e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—breast cancer	1.36e-06	1.51e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CD—breast cancer	1.35e-06	1.49e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALB—breast cancer	1.33e-06	1.47e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTEN—breast cancer	1.31e-06	1.44e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CAV1—breast cancer	1.3e-06	1.44e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—breast cancer	1.28e-06	1.41e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTEN—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CG—breast cancer	1.19e-06	1.31e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CB—breast cancer	1.18e-06	1.3e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—breast cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CD—breast cancer	1.04e-06	1.15e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—breast cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALB—breast cancer	1.03e-06	1.14e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTEN—breast cancer	1.02e-06	1.12e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—breast cancer	9.84e-07	1.09e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—breast cancer	9.21e-07	1.02e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CB—breast cancer	9.08e-07	1e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—breast cancer	9e-07	9.94e-06	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—AKT1—breast cancer	8.43e-07	9.31e-06	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—breast cancer	8.4e-07	9.27e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTEN—breast cancer	7.85e-07	8.67e-06	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—AKT1—breast cancer	7.52e-07	8.31e-06	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—breast cancer	7.18e-07	7.92e-06	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—AKT1—breast cancer	6.86e-07	7.57e-06	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—AKT1—breast cancer	5.86e-07	6.47e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—breast cancer	5.54e-07	6.12e-06	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—AKT1—breast cancer	4.52e-07	5e-06	CbGpPWpGaD
